115 Results for "

relapsing

" in MedChemExpress (MCE) Product Catalog:
Products (115)

115 Results for "relapsing" in MCE Product Catalog:

86
86 Publications Verification
Art. -Nr.: HY-10224
CAS. Nr.: 404950-80-7
Reinheit:  99.37%
Synonyms: LBH589; NVP-LBH589
Target:  

HDAC Autophagy HIV Apoptosis

Forschungsgebiete:  

Cancer

Panobinostat (LBH589; NVP-LBH589) is a potent and orally active non-selective HDAC inhibitor, and has antineoplastic activities . Panobinostat induces HIV-1 virus production even at low concentration range 8-31 nM, stimulates HIV-1 expression in latently infected cells . Panobinostat induces cell apoptosis and autophagy. Panobinostat can be used for the study of refractory or relapsed multiple myeloma .
86
86 Publications Verification
Art. -Nr.: HY-10224A
CAS. Nr.: 960055-56-5
Reinheit:  98.67%
Synonyms: LBH589 lactate; NVP-LBH589 lactate
Target:  

HDAC HIV Autophagy Apoptosis

Forschungsgebiete:  

Infection Cancer

Panobinostat lactate is a potent and orally active non-selective HDAC inhibitor. Panobinostat lactate has antineoplastic activities. Panobinostat lactate effectively disrupts HIV latency. Panobinostat lactate induces cell apoptosis and autophagy. Panobinostat lactate can be used for the study of refractory or relapsed multiple myeloma .
85
85 Cited Publications
Art. -Nr.: HY-10224R
CAS. Nr.: 404950-80-7
Synonyms: LBH589 (Standard); NVP-LBH589 (Standard)
Forschungsgebiete:  

Infection Cancer

Panobinostat (Standard) (LBH589 (Standard)) is the analytical standard of Panobinostat (HY-10224). This product is intended for research and analytical applications. Panobinostat is a potent and orally active non-selective HDAC inhibitor, and has antineoplastic activities . Panobinostat induces HIV-1 virus production even at low concentration range 8-31 nM, stimulates HIV-1 expression in latently infected cells . Panobinostat induces cell apoptosis and autophagy. Panobinostat can be used for the study of refractory or relapsed multiple myeloma .
52
52 Cited Publications
Art. -Nr.: HY-15676
CAS. Nr.: 1229705-06-9
Reinheit:  99.93%
Synonyms: RG7388
Idasanutlin (RG7388) is an orally bioavailable MDM2 inhibitor with an IC50 of 6 nM. Idasanutlin disrupts MDM2-p53 binding, stabilizes and activates p53, triggering cell cycle arrest, apoptosis, and reduced cancer cell viability. Idasanutlin reduces EGFR protein expression and phosphorylation, suppresses downstream SHP2, MEK1/2, ERK1/2, AKT, mTOR, p70(S6K1), and S6 signaling. Idasanutlin induces mitochondrial ROS production, drives p38 MAPK phosphorylation, upregulates NOXA, and mediates caspase-3-dependent apoptosis and gasdermin E-mediated pyroptosis. Idasanutlin can be used for the research of TP53-mutant non-small cell lung cancer, T-cell acute lymphoblastic leukemia, colorectal carcinoma, melanoma, diffuse large B-cell lymphoma, mantle cell lymphoma, non-Hodgkin lymphoma, severe fever with thrombocytopenia syndrome, neuroblastoma, acute lymphoblastic leukemia, relapsed or refractory acute myeloid leukemia, osteosarcoma, solid tumors, and hematological tumors .
33
33 Cited Publications
Art. -Nr.: HY-101563
CAS. Nr.: 1616392-22-3
Reinheit:  99.51%
Synonyms: EPZ015938
GSK3326595 is a protein arginine methyltransferase 5 (PRMT5) inhibitor. GSK3326595 decreases SARS-CoV-2 infection, inhibits cancer cell proliferation and induces pro-inflammatory macrophage polarization and increases hepatic triglyceride levels without affecting atherosclerosis. GSK3326595 can be used for research of relapsed/refractory mantle cell lymphoma .
28
28 Cited Publications
Art. -Nr.: HY-112037
CAS. Nr.: 1570496-34-2
Reinheit:  99.68%
Synonyms: IACS-10759
IACS-010759 is an orally active, potent mitochondrial complex I of oxidative phosphorylation (OXPHOS) inhibitor. IACS-010759 inhibits proliferation and induces apoptosis in models of brain cancer and acute myeloid leukemia (AML) reliant on OXPHOS. IACS-010759 has the potential for relapsed/refractory AML and solid tumors research .
28
28 Cited Publications
Art. -Nr.: HY-112037A
CAS. Nr.: 1807523-99-4
Reinheit:  99.58%
Synonyms: IACS-10759 hydrochloride
IACS-010759 hydrochlorideis an orally active, potent mitochondrial complex I of oxidative phosphorylation (OXPHOS) inhibitor. IACS-010759 hydrochlorideinhibits proliferation and induces apoptosis in models of brain cancer and acute myeloid leukemia (AML) reliant on OXPHOS. IACS-010759 hydrochloride has the potential for relapsed/refractory AML and solid tumors research .
9
9 Cited Publications
Art. -Nr.: HY-P1240
CAS. Nr.: 149635-73-4
Synonyms: Myelin Oligodendrocyte Glycoprotein Peptide (35-55), mouse, rat
MOG (35-55) mouse, rat (Myelin Oligodendrocyte Glycoprotein Peptide (35-55), mouse, rat) is a minor component of CNS myelin. MOG (35-55) mouse, rat has encephalitogenic activity and induces T cell proliferative. MOG (35-55) mouse, rat induces Th1 cytokine response as well as relatively high levels of IgG antibodies. MOG (35-55) mouse, rat produces a relapsing-remitting neurological disease with extensive plaque-like demyelination. MOG (35-55) mouse, rat (MOG (35-55)) can be used for experimental autoimmune encephalomyelitis (EAE) modeling .
9
9 Cited Publications
Art. -Nr.: HY-10446
CAS. Nr.: 146464-95-1
Reinheit:  99.22%
Target:  

Antifolate Apoptosis

Forschungsgebiete:  

Cancer

Pralatrexate is an antifolate and is a potent dihydrofolate reductasean (DHFR) inhibitor with a Ki of 13.4 pM. Pralatrexate is a substrate for folylpolyglutamate synthetase with improved cellular uptake and retention. Pralatrexate has antitumor activities and has the potential for relapsed/refractory T-cell lymphoma treatment . Pralatrexate is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
9
9 Cited Publications
Art. -Nr.: HY-P1240A
Synonyms: Myelin Oligodendrocyte Glycoprotein Peptide (35-55), mouse, rat TFA
MOG (35-55) (MOG (35-55)) TFA is a minor component of CNS myelin. MOG (35-55) (TFA) has encephalitogenic activity and induces T cell proliferative. MOG (35-55) (TFA) induces Th1 cytokine response as well as relatively high levels of IgG antibodies. MOG (35-55) (TFA) produces a relapsing-remitting neurological disease with extensive plaque-like demyelination. MOG (35-55) (MOG (35-55)) TFA can be used for experimental autoimmune encephalomyelitis (EAE) modeling .
9
9 Cited Publications
Art. -Nr.: HY-P1240B
Synonyms: Myelin Oligodendrocyte Glycoprotein Peptide (35-55), mouse, rat acetate
Target:  

Peptides

MOG (35-55) (Myelin Oligodendrocyte Glycoprotein Peptide (35-55), mouse, rat) acetate is a minor component of CNS myelin. MOG (35-55) (acetate) has encephalitogenic activity and induces T cell proliferative. MOG (35-55) (acetate) induces Th1 cytokine response as well as relatively high levels of IgG antibodies. MOG (35-55) (acetate) produces a relapsing-remitting neurological disease with extensive plaque-like demyelination. MOG (35-55) (Myelin Oligodendrocyte Glycoprotein Peptide (35-55), mouse, rat) acetate can be used for experimental autoimmune encephalomyelitis (EAE) modeling .
7
7 Cited Publications
Art. -Nr.: HY-109117
CAS. Nr.: 1431304-21-0
Reinheit:  99.82%
Synonyms: ORY-1001
Forschungsgebiete:  

Cancer

Iadademstat (ORY-1001) is a highly potent, orally active and selective LSD1 (KDM1A) inhibitor with antileukemic activity. Iadademstat can be used for relapsed or refractory acute myeloid leukemia research .
6
6 Cited Publications
Art. -Nr.: HY-136328
CAS. Nr.: 2411759-92-5
Reinheit:  97.20%
Synonyms: SETD2-IN-1 TFA
Forschungsgebiete:  

Cancer

EZM0414 (SETD2-IN-1) TFA is the TFA salt form of EZM0414 (HY-144858). EZM0414 TFA is a potent, selective, orally active inhibitor of SETD2 (IC50=18 nM in SETD2 biochemical assay; IC50=34 nM in cellular assay). EZM0414 TFA can be used for the research of relapsed or refractory multiple myeloma and diffuse large B-cell lymphoma .
6
6 Cited Publications
Art. -Nr.: HY-12651A
CAS. Nr.: 90-34-6
Reinheit:  98.85%
Target:  

Parasite

Forschungsgebiete:  

Infection Cancer

Primaquine is a potent antimalaria agent and a potent gametocytocide in falciparum malaria. Primaquine prevents relapse in vivax and ovale malaria .
6
6 Cited Publications
Art. -Nr.: HY-12651
CAS. Nr.: 63-45-6
Reinheit:  99.28%
Synonyms: Primaquine phosphate; Primaquine bisphosphate
Target:  

Parasite

Forschungsgebiete:  

Infection Cancer

Primaquine diphosphate is a potent antimalaria agent and a potent gametocytocide in falciparum malaria. Primaquine diphosphate prevents relapse in vivax and ovale malaria .
6
6 Cited Publications
Art. -Nr.: HY-144858
CAS. Nr.: 2411748-50-8
Reinheit:  99.11%
Forschungsgebiete:  

Cancer

EZM0414 is a potent, selective, orally bioavailable inhibitor of SETD2 (IC50=18 nM in SETD2 biochemical assay; IC50=34 nM in cellular assay). EZM0414 can be used for the research of relapsed or refractory multiple myeloma and diffuse large B-cell lymphoma .
5
5 Cited Publications
Art. -Nr.: HY-109108
CAS. Nr.: 1809336-39-7
Reinheit:  99.68%
Synonyms: DS-3201
Forschungsgebiete:  

Cancer

Valemetostat (DS-3201), a first-in-class EZH1/2 dual inhibitor with IC50 values <10 nM. Valemetostat can be used for the research of relapsed/refractory peripheral T-cell lymphoma .
5
5 Cited Publications
Art. -Nr.: HY-109108A
CAS. Nr.: 1809336-93-3
Reinheit:  99.84%
Synonyms: DS-3201 tosylate
Forschungsgebiete:  

Cancer

Valemetostat (DS-3201) tosylate, a first-in-class EZH1/2 dual inhibitor with IC50 values <10 nM. Valemetostat tosylate can be used for the research of relapsed/refractory peripheral T-cell lymphoma .
4
4 Cited Publications
Art. -Nr.: HY-12288
CAS. Nr.: 1306760-87-1
Reinheit:  99.98%
Synonyms: RPC-1063
Target:  

LPL Receptor

Ozanimod (RPC-1063) is a CNS-penetrant sphingosine 1-phosphate (S1P) receptor modulator that binds with high affinity selectively to S1P receptor subtypes 1 (S1P1) and 5 (S1P5). Ozanimod has modulate effect for hS1P1 and hS1P5 receptor with EC50s of 1.03 nM and 8.6 nM, respectively. Ozanimod can be used for the research of relapsing multiple sclerosis (MS) .
4
4 Cited Publications
Art. -Nr.: HY-114778
CAS. Nr.: 1358715-18-0
Reinheit:  99.96%
Synonyms: SHR3162; Fuzuloparib
Target:  

PARP

Forschungsgebiete:  

Cancer

Fluzoparib (SHR3162) is a potent and orally active PARP1 inhibitor (IC50=1.46±0.72 nM, a cell-free enzymatic assay) with superior antitumor activity. Fluzoparib selectively inhibits the proliferation of homologous recombination repair (HR)-deficient cells, and sensitizes both HR-deficient and HR-proficient cells to cytotoxic agents. Fluzoparib exhibits good pharmacokinetic properties in vivo and can be used for BRCA1/2-mutant relapsed ovarian cancer research .